Spina bifida and pediatric cancers.


Journal

Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 5 5 2020
medline: 27 1 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

Spina bifida has been reported to co-occur with pediatric cancer, but comprehensive evaluations remained elusive. We investigated this co-occurrence in two large, population-based studies in Taiwan (N = 1900 cancer cases, 2,077,137 controls) and Denmark (N = 5508 cases, 137,700 controls). Analyses in Denmark were restricted to the period before prenatal diagnostics became available (2004) and pregnancy terminations of fetuses with birth defects became more common. Using national patient and cancer registries, we linked spina bifida and cancer diagnoses among cases and non-cases. The risk of spina bifida among all cancer cases was increased and similar in Denmark [odds ratio (OR)=8.4, 95% confidence interval (CI) 5.1-13.8] and Taiwan (OR = 8.5, 95% CI 4.0-17.8), particularly for central nervous system (CNS) tumors (Denmark: OR = 16.3, 95% CI 8.1-33.0; Taiwan: OR = 26.6, 95% CI 8.5, 83.1), including benign CNS tumors (Denmark: OR = 41.5, 95% CI 21.2, 81.4). These findings suggest the need for comprehensive investigation of shared risk factors in the link between spina bifida and pediatric cancer.

Identifiants

pubmed: 32364426
doi: 10.1080/08880018.2020.1760409
pmc: PMC7577564
mid: NIHMS1637317
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

630-636

Subventions

Organisme : NIEHS NIH HHS
ID : R03 ES021643
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA175959
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States

Références

PLoS One. 2013 Sep 20;8(9):e75428
pubmed: 24147155
Pediatr Blood Cancer. 2019 Jan;66(1):e27461
pubmed: 30255546
Pediatr Hematol Oncol. 2003 Apr-May;20(3):261-4
pubmed: 12637224
Am J Hum Genet. 1997 Mar;60(3):474-85
pubmed: 9042906
Am J Med Genet A. 2014 Sep;164A(9):2250-5
pubmed: 24934283
Cancer Epidemiol. 2017 Aug;49:202-215
pubmed: 28715709
J Neurosurg. 1998 Nov;89(5):844-51
pubmed: 9817426
Neurotoxicology. 2017 Jul;61:20-31
pubmed: 27000518
J Pediatr. 2012 Jun;160(6):978-83
pubmed: 22244463
JAMA Oncol. 2019 Jun 20;:
pubmed: 31219523
Neuro Oncol. 2013 Nov;15 Suppl 2:ii1-56
pubmed: 24137015
J Pediatr. 1998 Nov;133(5):617-23
pubmed: 9821417
Birth Defects Res. 2019 Feb 1;111(3):151-158
pubmed: 30561844
Acta Oncol. 1991;30(5):579-81
pubmed: 1892674
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36
pubmed: 25192704
Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1933-41
pubmed: 22941336
Acta Oncol. 2009;48(5):791-800
pubmed: 19225948
Biomed Res Int. 2018 Feb 1;2018:9203985
pubmed: 29487873
Eur J Pediatr. 1990 May;149(8):594-5
pubmed: 2161343
Am J Public Health. 2016 Jan;106(1):e24-34
pubmed: 26562127
Int J Cancer. 2020 Sep 1;147(5):1343-1353
pubmed: 32020595
PLoS One. 2017 Jul 27;12(7):e0181246
pubmed: 28749971
PLoS One. 2013 Jul 17;8(7):e69077
pubmed: 23874873

Auteurs

Julia E Heck (JE)

Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
Jonsson Comprehensive Cancer Center, University of California, UCLA, Los Angeles, California, USA.

Pei-Chen Lee (PC)

Department of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.

Chia-Kai Wu (CK)

Department of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.

Chung-Yi Li (CY)

Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan.
Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan.

Di He (D)

Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, California, USA.

Noah Federman (N)

Department of Pediatrics, Geffen School of Medicine, University of California, UCLA, Los Angeles, California, USA.

Fei Yu (F)

Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.

Jorn Olsen (J)

Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.

Beate Ritz (B)

Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, California, USA.

Onyebuchi A Arah (OA)

Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, California, USA.

Johnni Hansen (J)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH